全文获取类型
收费全文 | 2871篇 |
免费 | 367篇 |
国内免费 | 79篇 |
专业分类
耳鼻咽喉 | 11篇 |
儿科学 | 67篇 |
妇产科学 | 7篇 |
基础医学 | 265篇 |
口腔科学 | 79篇 |
临床医学 | 127篇 |
内科学 | 212篇 |
皮肤病学 | 32篇 |
神经病学 | 51篇 |
特种医学 | 119篇 |
外国民族医学 | 1篇 |
外科学 | 1888篇 |
综合类 | 265篇 |
现状与发展 | 2篇 |
预防医学 | 16篇 |
眼科学 | 68篇 |
药学 | 48篇 |
中国医学 | 13篇 |
肿瘤学 | 46篇 |
出版年
2023年 | 47篇 |
2022年 | 55篇 |
2021年 | 146篇 |
2020年 | 147篇 |
2019年 | 162篇 |
2018年 | 155篇 |
2017年 | 167篇 |
2016年 | 119篇 |
2015年 | 99篇 |
2014年 | 184篇 |
2013年 | 199篇 |
2012年 | 115篇 |
2011年 | 145篇 |
2010年 | 132篇 |
2009年 | 144篇 |
2008年 | 157篇 |
2007年 | 141篇 |
2006年 | 131篇 |
2005年 | 138篇 |
2004年 | 118篇 |
2003年 | 100篇 |
2002年 | 85篇 |
2001年 | 65篇 |
2000年 | 50篇 |
1999年 | 45篇 |
1998年 | 36篇 |
1997年 | 48篇 |
1996年 | 29篇 |
1995年 | 24篇 |
1994年 | 23篇 |
1993年 | 19篇 |
1992年 | 17篇 |
1991年 | 11篇 |
1990年 | 10篇 |
1989年 | 12篇 |
1988年 | 11篇 |
1987年 | 3篇 |
1986年 | 5篇 |
1985年 | 3篇 |
1984年 | 2篇 |
1983年 | 4篇 |
1982年 | 6篇 |
1980年 | 1篇 |
1979年 | 2篇 |
1978年 | 2篇 |
1977年 | 2篇 |
1973年 | 1篇 |
排序方式: 共有3317条查询结果,搜索用时 15 毫秒
1.
《Seminars in Arthroplasty》2015,26(2):108-111
Bone loss is commonly encountered during revision total knee arthroplasty (TKA). Small defects can be adequately managed with cement filling (with or without screws), modular prosthetic augments, and morselized allograft. For larger defects, cancellous impaction grafting and structural allografts have traditionally been utilized. More recently, highly porous tantalum cones and titanium sleeves have been designed to achieve axial and rotational stability in the metaphysis and subsequent biologic fixation. Sleeves are linked to one type of prosthesis, whereas cones are unlinked and can be used with any implant design. Multiple studies have demonstrated excellent survivorship and radiographic osseointegration at mid-term follow-up. This article provides a review of contemporary methods of bone loss management with a focus on highly porous metals and an emphasis on the authors’ preferred method for managing the severe bone loss in revision TKA. 相似文献
2.
文题释义:肱骨近端骨折:肱骨近端包括肱骨头及大结节、小结节,中老年人骨质疏松及低能量损伤可导致肱骨近端骨折。
同种异体腓骨:取自于人体异体,经过加工处理,去除其免疫原性,保留其骨性结构,可用于移植修复骨缺损,起到支撑作用。
背景:肱骨近端骨折是临床常见骨折,但对肱骨近端内侧柱缺乏支撑的骨折目前仍是治疗难点,并发症常见,失败率较高。
目的:比较解剖锁定钢板联合同种异体腓骨与单纯解剖锁定钢板治疗肱骨近端骨折的疗效。
方法:使用计算机检索PubMed、Embase、Cochrane Library、Google Scholar、中国知网、万方、维普数据库,检索时间均从建库到2020年2月。检索国内外关于对比研究解剖锁定钢板联合同种异体腓骨与单纯解剖锁定钢板治疗肱骨近端骨折疗效的文献。2名研究员根据纳入和排除标准分别独立筛选文献,提取数据,评估文献中的偏倚风险。纳入12篇相关文献使用RevMan 5.2软件将以下指标进行Meta分析,包括影像学数据、功能评分和并发症。结果与结论:①通过文献检索、根据纳入和排除标准,12篇文献纳入研究,其中11篇为回顾性队列研究,1篇为随机对照研究;纳入研究文献质量高,但GRADE证据质量级别较低。②共纳入958例患者,其中解剖锁定钢板联合同种异体腓骨组411例,单纯解剖锁定钢板组547例;③Meta分析结果显示,解剖锁定钢板联合同种异体腓骨组术后1年肱骨头高度差值(MD=-2.40,95%CI:-2.49至-2.31)、颈干角差值(MD= -6.14,95%CI:-6.62至-5.67)、目测类比评分(MD=-0.22,95%CI:-0.35至-0.08)、肩关节功能评分(MD=4.12,95%CI:2.18-6.06),上肢伤残评分(MD=-10.32,95%CI:-13.44至-7.19)、术后2年的目测类比评分(MD=-0.37,95%CI:-0.55至-0.19)、肩关节功能评分(MD=5.07,95%CI:2.86-7.27)、总体并发症(OR=0.31,95%CI:0.20-0.48)及肱骨头螺钉切出(OR=0.25,95%CI:0.11-0.55)均明显优于单纯解剖锁定钢板组(P < 0.05),肱骨头坏死(OR=0.94,95%CI:0.47-1.88),两组间差异无显著性意义(P > 0.05);④因此,较弱的证据提示,肱骨近端解剖锁定钢板联合同种异体腓骨治疗肱骨近端骨折的短期疗效优于解剖锁定钢板,可减少并发症的发生,促进功能恢复。ORCID: 0000-0002-8486-3932(阳运康)
中国组织工程研究杂志出版内容重点:人工关节;骨植入物;脊柱;骨折;内固定;数字化骨科;组织工程 相似文献
3.
4.
5.
Roberto V.P. Ribeiro Mitesh V. Badiwala Danny Ramzy Laura C. Tumiati Vivek Rao 《The Journal of thoracic and cardiovascular surgery》2019,157(2):615-625.e1
Objective
Hypertonic saline (HTS) has potent immune and vascular effects. We assessed recipient pretreatment with HTS on allograft function in a porcine model of heart transplantation and hypothesized that HTS infusion would limit endothelial and left ventricular (LV) dysfunction following transplantation.Methods
Heart transplants were performed after 6 hours of cold ischemic storage. Recipient pigs were randomized to treatment with or without HTS (7.5% NaCl) before cardiopulmonary bypass (CPB). Using a myograft apparatus, coronary artery endothelial-dependent (Edep) and -independent (Eind) relaxation was assessed. LV performance was determined using pressure-volume loop analysis. Pulmonary interleukin (IL)-2, IL-6, and tumor necrosis factor (TNF)-α expression was measured.Results
Weaning from CPB and LV performance after transplantation were improved in HTS-treated animals. Successful weaning from CPB was greater in the HTS-treated hearts (8 of 8 vs 2 of 8; P < .05). Mean LV functional recovery was improved in the HTS-treated animals, as assessed by preload recruitable stroke work (65 ± 10% vs 27 ± 10%; P < .001) and end-systolic elastance (55 ± 7% vs 37 ± 4%; P < .001). Treatment with HTS resulted in improved Edep (mean maximum elastance [Emax], 56 ± 5% vs 37 ± 7%; P < .001) and Eind (mean Emax%, 77 ± 6% vs 52 ± 4%; P < .001) vasorelaxation compared with control. Pulmonary expression of IL-2, IL-6, and TNF-α increased following transplantation, whereas HTS therapy attenuated IL production (P < .001). Transplantation increased plasma TNF-α levels and LV TNF-α expression, whereas HTS prevented this up-regulation (P < .001).Conclusions
Recipient HTS pretreatment preserves allograft vasomotor and LV function, and HTS therapy limits CPB-induced injury. HTS may be a novel recipient intervention to prevent graft dysfunction. 相似文献6.
Martine C M Willems L W Ernest van Heurn Geert W Schurink Frank M van der Sande Jan H M Tordoir 《Nephrology, dialysis, transplantation》2006,21(12):3583-3584
7.
Tacrolimus Exposure and Evolution of Renal Allograft Histology in the First Year After Transplantation 总被引:1,自引:1,他引:0
M. Naesens E. Lerut B. V. Damme Y. Vanrenterghem D. R. J. Kuypers 《American journal of transplantation》2007,7(9):2114-2123
Tacrolimus has a narrow therapeutic window and is characterized by a large inter-individual variability in bioavailability. The impact of tacrolimus exposure on subclinical evolution of graft histology has not been studied in renal recipients. This analysis included 239 protocol biopsies (obtained at implantation, 3 and 12 months) of 120 consecutive kidney recipients treated with tacrolimus, mycophenolate mofetil (MMF) and corticosteroids. Biopsies were scored according to the Banff 2001 criteria and a chronicity score was calculated. Prospective pharmacokinetic data were included in the analysis (5544 tacrolimus predose blood concentrations and tacrolimus AUC(0-12) at 3 and 12 months). Higher donor age and higher number of human leukocyte antigen-DR (HLA-DR) mismatches were independent predictors of subclinical acute rejection at 3 months, present in 8.7% of patients. The number of HLA-DR mismatches was independently associated with biopsy-proven clinical acute rejection. Biopsy-proven acute rejection episodes and low mean tacrolimus exposure were independently associated with higher increase in chronicity scores between 3 and 12 months after transplantation. This observational study suggests that rejection phenomena and immune-mediated mechanisms remain important in the early progression of chronic allograft pathology. Tacrolimus doses or systemic exposure were not associated with lesions of calcineurin inhibitor nephrotoxicity, suggesting that other factors determine susceptibility to tacrolimus nephrotoxicity. 相似文献
8.
同种异体骨与自体骨移植治疗青少年脊柱侧凸的比较研究 总被引:3,自引:1,他引:2
[目的]观察同种异体骨移植与自体骨移植治疗青少年脊柱侧凸的临床效果.[方法]对1996~2006年本科收治的63例青少年脊柱侧凸患者的临床资料,采用回顾性"病例-对照"研究方法进行分析,A组(同种异体骨移植组)32例,10~15岁,平均12.2岁;Cobb's角38°~113°,平均62°;B组(自体髂骨移植组)31例,年龄9~14岁,平均12.4岁;Cobb's角41°~105°,平均54°.所有患者均选择中华长城椎弓根内固定系统经后路矫正,术后定期随访并对临床效果进行评估.[结果]出院后2个月即开始随访,随访时间18~24个月,平均26个月;亦无严重并发症发生;A组的手术时间、失血量较B组患者减少,组间具有统计学意义(P<0.01).[结论]两组患者具有相似的临床效果,在严格掌握适应证,充分术前准备、正确手术操作、及时术后处理的前提下,同种异体骨移植能够有效替代自体髂骨移植治疗青少年脊柱侧凸. 相似文献
9.
Vascular Endothelial Growth Factor Expression and Cyclosporine Toxicity in Renal Allograft Rejection 总被引:3,自引:0,他引:3
B. Handan Özdemir F. Nurhan Özdemir Nihan Haberal Remzi Emiroglu Beyhan Demirhan Mehmet Haberal 《American journal of transplantation》2005,5(4):766-774
The aim of this study was to evaluate the influence of vascular endothelial growth factor (VEGF) on renal function and on development of interstitial fibrosis (IF) in renal allografts. Tubular and interstitial expressions of VEGF and TNF-α, and density of macrophages in the interstitium were examined in 92 patients with nonrejected kidneys, acute rejection (AR), chronic allograft nephropathy (CAN), borderline changes (BC) and acute cyclosporin A (CsA) toxicity. Follow-up biopsy specimens from patients with AR and BC were evaluated for development of IF. A significant difference in tubular and interstitial VEGF expressions was found between patients with AR, BC, CAN and CsA toxicity (p < 0.001). Macrophage infiltration was positively correlated with VEGF and TNF-α expressions (p < 0.001). VEGF expression increased with increasing expression of TNF-α (p < 0.001). Renal function in first 6 months after initial biopsy was better in patients with marked tubular VEGF expression (p < 0.01); however, in follow-up, development of IF and graft loss was found earlier in these patients (p < 0.01 and p < 0.05, respectively). Increased renal VEGF expression has protective properties immediately following renal allograft but allows for increased risk of early IF, and therefore poor graft outcome in the long term. 相似文献
10.
Histamine-type 2 antagonists (H2-blockers) as represented by cimentidine have been shown to adversely affect renal allograft function, particularly when coadministered
with cyclosporine, currently a major immunosuppressant. To determine whether or not a newer and more powerful H2-blocker, famotidine, would produce similar adverse effects, we assessed seven cyclosporine-treated renal allograft recipients
with regard to changes in their renal function on or off the H2-blocker over a one-week period. Neither the administration nor withdrawal of famotidine (20–40 mg/day) resulted in any significant
changes in serum creatine, BUN, urine output or cyclosporine trough levels, suggesting that famotidine can be safely administered
as an H2-blocker to cyclosporine-treated renal allograft recipients. 相似文献